• Dec 8
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Identifying and targeting histone modifying enzymes critical in tumor cell survival after androgen deprivation therapy Zachery Shcultz Jarrard Laboratory Optimizing the efficacy of standard-of-care anti-microtubule therapies Caleb Carlsen Weaver Laboratory  

  • Nov 24
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Investigating Nonsense-Mediated Decay as a Restriction Factor for EBV Reactivation Emilie Greene Advisor: Eric Johannsen, MD Characterizing SIV latency with a novel in-vitro model MegAnn Haubold Advisor: Matt Reynolds, PhD  

  • Nov 17
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Nuclear Phosphoinositides on p53: A Novel Therapeutic Target for Mutant p53 Cancers Muhammad Salah Cryns Laboratory Creating New Models for Male Breast Cancer: Hormone-Dependent Tumorigenesis using the ACI rat Kasey Mitchell Xu Laboratory  

  • Nov 10
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Leveraging dose heterogeneity from radiopharmaceutical therapy enhances Lutetium-177 anti-tumor efficacy via increased immune response Maya Takashima Morris Laboratory Spatial and Epigenetic Mechanisms of AAV2 Persistence Rhiannon Abrahams Majumder Laboratory  

  • Nov 3
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Combining tumor-specific vaccination with radiopharmaceutical therapy to enhance anti-tumor immunity Daeun Shim McNeel Laboratory Allele salvaging: An unexpected allele provides a therapeutic path for glaucoma Alex Veith, PhD Bradfield Laboratory  

  • Oct 27
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Modeling ER+ metastatic breast cancer in rats Carstyn Joiner Xu Laboratory  

  • Oct 20
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Distinguishing LMP2A from BCR Isotype Associated Effects in Epstein-Barr Virus Transformed Cells Mariah Riel Johannsen Laboratory Complement Receptor 1 and Notch 2 are surface mediators of infection by Kaposi sarcoma-associated herpesvirus (KSHV) in human B cells Beniah Brumbaugh Sugden Laboratory  

  • Oct 13
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    CTCF regulates AAV and recombinant AAV lifecycle through changes in the viral chromatin landscape Clairine Larsen Majumder Laboratory Gain-of-Function ASXL1 Mutation Synergizes with Oncogenic NRAS to Drive CMML Development and AML Transformation Esra’a Keewan, PhD Zhang Laboratory  

  • Oct 6
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Is EBV gene expression dose-dependent on DNA copy number? Madilyn Ellis Advisor: Bill Sugden, PhD    

  • Sep 29
    McArdle Trainee Seminar Series (Student/Postdoc)

    6571 WIMR II

    Single-Cell-Informed Microphysiological System Replicates in vivo Macrophage Regulation of CD8+ T Cell Migration in Renal Cell Carcinoma Yuanshan Li Beebe Laboratory Deploying bioinformatics to explore the genetics of Diffuse Large B cell Lymphoma (DLBCL) and EBV Quincy Rosemarie, PhD Sugden Laboratory